KMB: Yield Tempts, But Growth and Cash Coverage Remain Elusive
Read source articleWhat happened
Kimberly-Clark's stock has slid ~22% over the past year, pushing the dividend yield above 5%, yet the company's underlying challenges persist. The Seeking Alpha article highlights that while the yield is compelling, sluggish growth and persistent inflation warrant a hold rating. Our DeepValue analysis reinforces this caution, noting that the dividend is not covered by operating free cash flow (118.5% payout ratio in 9M25) and that the massive Kenvue acquisition brings integration risk and Tylenol litigation overhang. North America margin pressure and tariff headwinds continue to offset productivity gains, while international segments provide some offset but not enough to move the needle. With Kenvue benefits back-end loaded and material upside unlikely before 2027, the stock offers limited near-term catalysts beyond its yield.
Implication
KMB's yield is attractive only if the dividend is safe, but it is not. With OFCF payout above 100%, net debt set to surge post-Kenvue, and Tylenol legal risks unresolved, the dividend is vulnerable. Even after the 22% decline, the stock trades at 16.5x P/E and 9.8x EV/EBITDA—hardly a bargain given the balance-sheet strain. Unless management provides explicit deleveraging targets and restores FCF coverage, the risk/reward skews negative. Reassessment in 6-12 months once Kenvue synergy trajectory and litigation outcomes are clearer.
Thesis delta
The new article does not change our bearish thesis but reinforces it by confirming the yield allure masks fundamental strain. The market narrative is shifting from 'turnaround with a safe dividend' to 'high-risk yield trap with execution heavy lifting.' The key delta is the acknowledgment that growth, not just margin recovery, is now the missing piece—organic volume growth remains low-single-digit, and Kenvue will not provide a growth kicker until at least 2027. This deepens our conviction that KMB is a potential sell, with an attractive entry only below $90.
Confidence
medium